Australia markets close in 18 minutes

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
8,710.00+151.00 (+1.76%)
At close: 5:36PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
29,528,000
26,617,000
24,384,000
22,090,000
22,465,000
Cost of revenue
6,950,000
5,299,000
4,921,000
4,936,000
4,318,000
Gross profit
22,578,000
21,318,000
19,463,000
17,154,000
18,147,000
Operating expenses
Research development
6,978,000
6,213,000
6,059,000
5,932,000
5,757,000
Selling general and administrative
12,580,000
11,896,000
10,723,000
10,362,000
10,303,000
Total operating expenses
18,366,000
17,624,000
16,463,000
15,644,000
15,855,000
Operating income or loss
4,212,000
3,694,000
3,000,000
1,510,000
2,292,000
Interest expense
1,240,000
1,272,000
1,402,000
1,366,000
713,000
Income before tax
4,392,000
3,916,000
1,548,000
1,993,000
2,227,000
Income tax expense
624,000
772,000
321,000
-57,000
-641,000
Income from continuing operations
3,768,000
3,144,000
1,227,000
2,050,000
2,868,000
Net income
3,771,000
3,196,000
1,335,000
2,155,000
3,001,000
Net income available to common shareholders
3,771,000
3,196,000
1,335,000
2,155,000
3,001,000
Basic EPS
-
2.44
1.03
1.70
2.37
Diluted EPS
-
2.44
1.03
1.70
2.37
Basic average shares
-
1,312,000
1,301,000
1,267,000
1,266,000
Diluted average shares
-
1,313,000
1,301,000
1,267,000
1,267,000
EBITDA
-
8,337,000
6,712,000
7,112,000
5,976,000